🇺🇸 FDA
Pipeline program

iCasp9M28z T cell infusions

15-007

Phase 2 gene_therapy active

Quick answer

iCasp9M28z T cell infusions for Malignant Pleural Disease is a Phase 2 program (gene_therapy) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Malignant Pleural Disease
Phase
Phase 2
Modality
gene_therapy
Status
active

Clinical trials